Chrysin protects human osteoarthritis chondrocytes by inhibiting inflammatory mediator expression via HMGB1 suppression
- 4 December 2018
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 19 (2) , 1222-1229
Abstract
High-mobility group box chromosomal protein (HMGB-1) contributes to osteoarthritis (OA) by modulating various oxidative, inflammatory and apoptotic signaling pathways. The effect of chrysin (CH), a natural plant flavonoid, and its functional interaction with HMGB-1, was investigated in a chondrocyte model of OA. Human chondrocytes were pre-treated with CH, and then subsequently treated with IL-1 to induce the formation of chondrocytes similar to those found in OA joints. Next, the expression level of HMGB-1 was determined by immunofluorescence and western blot analysis. Additionally, inflammatory factor expression was measured by ELISA, and cell apoptosis was analyzed with flow cytometry. To further explore the effects of CH, HMGB-1 expression was silenced following CH treatment with small interfering (si)RNA. The results demonstrated that CH inhibited cell apoptosis, dose-dependently reduced matrix metalloproteinase (MMP) 13, collagenase and IL-6 expression, and increased collagen -1 (II) chain (COL2A1) expression in human osteoarthritis chondrocytes. These effects of CH were accompanied by decreased HMGB-1 expression. Additionally, the expression of MMP13, collagenase, IL-6 and COL2A1, as well as apoptosis, was significantly reduced by HMGB-1 siRNA. These results demonstrated that HMGB-1 is critical for the protective effect of CH on human osteoarthritis chondrocytes, including cell apoptosis and inflammatory factor inhibition, which suggests that CH may have potential therapeutic effect in treating OA by protecting human osteoarthritis chondrocytes via HMGB1 suppression.Keywords
This publication has 39 references indexed in Scilit:
- Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End ProductsPLOS ONE, 2013
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012
- Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar ratsBritish Journal of Nutrition, 2012
- Inhibition of Gsk3β in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathwayOsteoarthritis and Cartilage, 2011
- HMGB1 and RAGE in Inflammation and CancerAnnual Review of Immunology, 2010
- CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune ResponsesScience, 2009
- Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritisArthritis & Rheumatism, 2008
- Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritisArthritis & Rheumatism, 2005
- Successful treatment of collagen‐induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activityArthritis & Rheumatism, 2003
- High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokineArthritis & Rheumatism, 2003